click enter text
upgrad outperform pt
upsid risk consensu ep valuat fair upgrad
outperform rais price target higher estim
reflect higher top line gross margin outlook oper leverag
year ebit margin contract reflect lap invest
production/plan facil china europ gm pressur well
duplic hq spend europ legal spend unwind
revenu estim reflect evid share stabil
execut commerci rollout new territori detail exhibit
line consensu sale ep
target price impli multipl ev wolf ebitda
compar current trade multipl ev consensu ebitda
model ebitda growth acceler
show expect share shift away xray/mmm
fade sinc open door acceler america growth
also note consum survey conduct novemb
indic awar smiledirectclub alreadi rel high
nearli well known invisalign indic penetr dtc competitor
like level full survey find detail survey note
margin recoveri key increment upsid algn cost per
align manufactur increas sinc compani began
expand treatment plan manufactur capac europ
china exhibit above-consensu forecast assum
manufactur cost per align return histor norm next three
year confirm recoveri like near term
structur cost per align theori lower histor norm
freight cost lower new facil highli autom
commit enabl dentist custom easili start lower-cost case
custom regular visit give access increment case
opportun north america present structur risk sdc
theori deliv lowest-frict treatment partner clinician
option embed valuat model
trade fundament data
upsid target
price
report limit sole use client wolf research pleas refer disclosur section locat end
report analyst certif import disclosur disclosur
page
note wolf consensu est non-gaap
compani data factset wolf research price
highest
out-performance
repres attract return profil
coverag spite expect
materi chang ebitda multipl put
simpli easier comp america shift
revenu mix re-emerg
oper leverag make fastest
prospect multipl expans
spite
estim ahead consensu
approxim in-lin consensu estim
spite embed deceler itero
line ep estim well ahead
consensu expect margin recoveri
post invest meet
manag greater ny dental
meet compani la vega gener
convict path margin improv
compani lap product legal treatment
plan spend steps-up last year
sens also like tax leverag
model beyond forecast clariti
limit outlook tie shift eu domicil
switzerland netherland
expect competit limit impact
orthodontist dentist survey
indic competit clear align product
xray/mmm/stmn limit
expect competit trial stabl
also note experi aus/nz
franchis acceler spark
launch posit indic limit impact
invest drive benefit algn
digit rep invest pay
path invest clearer
concierg platform pay us
latam invest earli roughli doubl
number potenti custom us brazil
alon year runway china
page
exhibit stack volume growth emb slow us
part
competit proven inferior discuss
compani align space china
confirm non-u manufactur key
competit advantag roll
novemb healthcar
confer host cfo john morici svp
discuss transit
growth rate expect stabil
signific increas sale rep hire
us china took
time ramp contribut growth rate
geographi increas focus
market spend drive patient awar
volum year
innov take sdc territori
dentist partner materi upsid option
rel model critic messag
align gener dentist gp custom la
vega gp summit novemb compani
commit work
support dentist custom
softwar market smiledirectclub sdc
loom larg gp custom base
typic concentr lower end case
also sdc focu creat modest notabl
price volum pressur algn dentist
custom key compon thesi
would deploy softwar support
gp custom
selection/planning/follow essenti deploy
at-hom product dentist front
line pursu consum sdc
go approach would turn regular
dental visit sell opportun
dentist could propos treatment plan deliv
align ultim one increment
invisalign
conveni treatment via sdc thesi
earli announc made gp
summit meet event confirm
move direct soon
explicitli add at-hom back model
expect higher visibl approach
treatment
page
revenu profit dilut shipment growthna orthodontistsna dentistsinternationalforecast
remain leader competit look stabl grow headwind
exhibit expect budget shift show smaller plan move share away align
note nov survey dentist orthodontist may survey dentist orthodontist overlap respond
exhibit usag expect continu track higher
note nov survey dentist orthodontist
exhibit price match uncommon confirm price stabil
note nov survey dentist orthodontist
risk look mitig time
initi specter competit disrupt
china off-set structur optim regard
posit novemb survey
result confirm recent dilig suggest
mainlin align competitor materi
risk volum growth object
xray/mmm/stmn take share
deceler rate same-stor basi open
door acceler us growth
upsid risk consensu
view
novemb survey cover orthodontist
dentist also may
survey key find survey
share shift seem modestli less signific
plan away vs may
survey share shift indic
novemb survey meaning smaller
indic may survey away
vs may survey seen exhibit
survey also indic done less
price match previous expect
also consist weve seen algn
number commentari competitor
page
/straumanndentsplysuresmil clarityormco sparkclearguideschein slx /revealin-offic may may mild mild stage mild moder upto stage moder tosever unlimit align usag case price match notofferedy use ity use itov last month offer price match invisalign align may survey survey
intra-or scan spend exceed expect april survey expect increas
next month posit market lead itero also posit
strong primescan introduct upgrad program like drive increas io
spend purchas interest digit scanner modestli posit well approxim
respond indic intend purchas digit scanner next month itero continu lead
intend purchas carestream also well survey
exhibit intra-or scan spend total spend
exhibit purchas interest digit scanner next
margin set improv period invest
visibl margin expans clarifi half ebit margin compress
model tie capac expans much remaind tie commerci launch new
region move set base expens leverag model margin expans
essenti revers pressur novemb reiter lrp full indic expect
return margin compar fade litig spend
lower tax rate upsid risk number
exhibit expect manufactur cost per align
declin go forward leverag china facil
exhibit custom acquisit cost steadi
organ margin chang volatil
note cost relat treatment plan facil china start cost
relat manufactur facil china start cost relat treatment
plan facil germani spain start
page
scan spend total spendpast monthsnext monthsnext mo expect budget io apr survey weight average survey weight average ormcoothernotpurchasingdigit scanner respondentscurr ownplan purchas next cog organ margin changecustom acquisiton costsorgan omx/ebitforecast
exhibit organ ebit margin forecast conserv
note reflect impact legal spend facil transit
volum trend util
exhibit case volum growth expect slow china
consum caution us dtc competit
exhibit averag sell price trend pressur fx
page
exhibit north america dentist util impact
exhibit north america dentist custom growth level
growth expect continu
exhibit china growth recov difficult
consist benefit direct sale brazil
note data earn call commentari
note data data specif yet report
exhibit teen growth moder adult segment also
exhibit digit mix continu increas help gross
note map mandibular advanc introduc march invisalign
first introduc april pre-teen children
note ww digit submiss base report america
digit submiss weight case volum yet report
page
util trendna dentist lh lh na ortho rh forecast basena orthodontistsna saleschina growth salesoth growth growthgrowth patient digit submiss total ww digit submiss total digit submiss total
shape s-curv import discretionari segment market sinc
enjoy supernorm growth benefit strong economi improv dtc/sell model digit
intern expans sdc jointli penetr emerg dtc/aesthet market
differ approach believ us opportun cumul case long penetr curv
case typic opportun penetr per year impli case per
year run rate sdc jointli would achiev exit impli deceler discretionari
segment market horizon consum genom experi instruct heavi
promotion/pric reduct phase follow sharper slow see sign track work
near term risk worth monitor
sdc rise sdc far tell modest impact algn growth anyth sdc case
complex remain modest vs algn month case progress slowli vs algn per-month basi
impli averag month-equival complex sdc month vs algn month algn
estim overlap accur moreov sdc rise correspond slow
emerg market medium term sdc could prove true competitor
dramat chang product
mainlin competit algn us pc-enabl product ip expir competitor
mmm//dhr start ramp manufactur product refin year later
readi make commerci push evid growth trend estim x-ray
take market per quarter expect enter market later meaning
work captur posit assum deceler price pressur us account
risk see acceler asp reduct mmm/xray solid product offer sale
team make custom acquisit challeng price difficult margin
cut express price promot effort smart move front-run challeng mainlin comp
reveal may biggest risk reveal compel low-end product price
promot effort start stmn horizon lack critic spot stmn
softwar limit io promot align
discretionari macro signal deterior macro limit import
major volum growth profil align captur mix bracket discretionari macro key
variabl vet macro correl almost year one find help roll
introduc increment risk worth volum growth
china tariff substitut angel invisalign remain risk work suggest anti-
american sentiment china high grow phase one trade deal partli eas tension
china growth howev alreadi fallen sharpli guidanc assum recoveri remain clearli
superior product clinician focus patient outcom importantli china fall
intern sale latam/europ jointli larger acceler notabl acceler intern
channel growth spite china slowdown find hard anticip big reacceler
china lap itero launch china macro moder
page
page
yieldfcf compound-annual-growth-rate ebitda compound-annual-growth-rate ev-ebitda vs estimate ebitda compound-annual-growth-rate tool price-to-earnings premium dental averag median price-to-earnings premium compound-annual-growth-rate
note figur million unless state per-shar term
page
 cog gross margin sales/mktg total opex interest/oth equiti sdc non-oper pre-tax incom tax net incom dilut share margin
note figur million unless state per-shar term
page
